| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_1_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_2_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_3_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_4_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_5_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector1_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector2_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector3_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector4_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector5_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_1_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_2_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_3_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_4_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_5_M62 | Genotype:PRODH2_OE | Treatment:PRODH2 | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector1_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector2_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector3_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector4_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
| HILIC POSITIVE ION MODE | 20181221_hProdh2_OE_Vector5_M62 | Genotype:Vector_OE | Treatment:Control | ppm |
Return to study ST002085 main page
Download data matrix(A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy(Part 1) HILIC POSITIVE ION MODE)
Download data matrix(A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy(Part 1) HILIC POSITIVE ION MODE)
- Metabolomics Workbench
|